Mevion Medical Systems S250 at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine Moves to Clinical Commissioning

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LITTLETON, Mass.--(BUSINESS WIRE)--Today, Mevion Medical Systems announced moving from acceptance testing to the clinical commissioning phase of its MEVION S250 Proton Therapy System installed at the S. Lee Kling Center for Proton Therapy at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO. The MEVION S250 is a unique proton therapy device designed to deliver the same precise, non-invasive treatment capabilities and advantages of conventional systems but with a significantly reduced size, improved reliability, efficient clinical workflow and lower implementation and operational costs. This important milestone marks the handover and operational control of the first MEVION S250 to the physics and radiation oncology proton teams from the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine for clinical commissioning and patient treatment.

Help employers find you! Check out all the jobs and post your resume.

Back to news